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Abstract- -The effects of the mouse major histocompatibility complex, H-2, on phospholipid methyl- 
transferase I and II activities were investigated on hepatocyte membranes from inbred, congenic and 
recombinant strains. Each methyltransferase was assayed individually by measuring the incorporation 
of radiolabel from S-adenosyl-L-[methyl-3H]methionine into endogenous phospholipids. Our results 
indicate that H-2 exerted a significant effect on methyltransferase I but not on methyltransferase 
II activity. Thus, as in lower eukaryotes, two distinct enzymes were involved in methylation of 
phosphotidylethanolamine (PE) to phosphatidylcholine (PC). In addition, this effect was localized to 
the K end of the major histocompatibility complex by the use of recombinant haplotypes. 
The mouse major histocompatibility complex, H-2, 
has been shown to influence intracellular cyclic AMP 
levels and glucagon binding to hepatocyte mem- 
branes [1,2]. It has also been suggested that the 
sequential methylation of membrane phospholipids 
mediates the transduction of a variety of receptor- 
modulated signals [3]. In view of these findings, we 
investigated the effects of 1-1-2 on phospholipid N- 
methylation in liver cell membranes from inbred 
strains of mice. The synthesis of phosphatidylcholine 
from phosphatidylethanolamine appears to involve 
two specific methyltransferases (MT I and MT II) 
which mediate the stepwise transfer of three methyl 
groups from S-adenosyl-L-methionine to the 
phospholipid intermediates [4]. By measuring the 
incorporation of radiolabel from S-adenosyl-L- 
[methyl-3H]methionine into endogenous phospho- 
lipids, we were able to assay each methyltransferase 
individually in hepatocyte membranes from inbred 
and H-2 congenic mice. Our results indicate that H- 
2 exerted a significant effect on mouse MT I activity 
but not on NiT II, supporting the theory that, as in 
lower eukaryotic organisms such as Saccharomyces 
cerevisiae [5] and Neurospora crassa [6], two enzymes 
are involved in transmembrane methylation. Fur- 
thermore, the H-2 effect was shown to map at the K 
end of the major histocompatibility complex. 
MATERIALS AND METHODS 
Unless otherwise indicated, the mice used were 
inbred from original stocks obtained from Jackson 
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Laboratories, Bar Harbor, ME. A.TL and A.TH 
mice were gifts from Dr. John Neiderhuber, Uni- 
versity of Michigan. All other recombinant haplo- 
types were donated by Dr. Jane Schultz, University 
of Michigan. 
Livers were rapidly excised from animals killed by 
cervical dislocation and minced finely in ice-cold 
I mM NaHCO3, pH 7.4. The SUSl~ension was homo- 
genized in a Teflon-glass homogenizer for five 
strokes at low speed with a Thomas model 45 homo- 
genizer and centrifuged for 1 min at 500 g. The pellet 
was discarded, and the supernatant fraction was 
recentrifuged for 10 min at 1500g. The resulting 
pellet was quick-frozen in a dry ice-ethanol bath and 
stored at - 2 0  ° until use. 
The pellets were thawed by vigorous shaking in 
the homogenization buffer, 50mM 4-(2-hydroxy- 
ethyl)-l-piperazine-ethanesulfonic acid (HEPES), 
10 mM NaF, and 15 mM ethyleneglycolbis(amino- 
ethylether)tetra-acetate (EGTA), pH 7.4 [7]. 
Methyltransferase activities were determined essen- 
tially as described by Hirata et al. [4]. The methyl- 
ation rate of endogenous phosphatidylethanolamine 
(PE) by MT I was obtained by measuring the incor- 
~Horation of radiolabel from S-adenosyl-L-[methyl- 
]methionine ([3H]SAM) into phosphatidylmono- 
methylethanolamine (PMME). The reaction 
medium contained 10mM MgC12, 0.1 mM sodium 
EDTA and 50mM sodium acetate, pH 6.5. Ten 
microliters (0.05 to 0.10 mg protein) of hepatocyte 
membrane extract in the homogenization buffer was 
added to a total volume of 50/A. The reaction was 
initiated by addition of 4/xM [3H]SAM and incubated 
for 30 min at 37 °. The assay was terminated by 
addition of 3 ml chloro form-methanol-HC1 
(2/1/0.02, by vol.) and 2ml of 0.1M KC1 in 50% 
methanol. The tubes were shaken for 15 min and 
centrifuged for 10 min at 2000 g. Following aspiration 
of the aqueous phase, the chloroform layer was 
rewashed with 2 ml of 0.1 M KC1 in 50% methanol; 
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Table 1. Methyltransferase activity in inbred and H-2 congenic strains of mice 
MT I activity MT II activity 
Strain* N (fmoles//~g protein) N (fmoles/~ug protein) Background H-2 type 
Inbred 
A/J 6 10.03 --- 0.50t 4 
C57BI./6J 6 19.44 ± 0.72 4 
C57BL/10Sn 2 20.20 ± 0.40 
DBA/2J 5 15.57 --- 0.12 2 
BALB/cJ 6 15.24 ± 0.64 2 
AKR 5 24.98 ± 0.12 2 
C3H 5 25.54 ± 1.42 
C57BR/cdJ 4 25.52 ± 0.28 
A/WYSn 6 20.96 ± 0.18 2 
Congenic 
A.SW 3 15.07 ± 0.61 
A.BYSn 4 20.58 ± 1.40 2 
B10.A 4 9.50 - 1.03 2 
B10.S 5 14.99 ± 0.41 
B10.BR 3 25.31 ± 0.64 
B10.D2 3 15.84 ± 0.18 
409.4 ± 9.14t A a 
392.8 - 3.81 C57BL(B) b 
NT:~ B b 
407.2 --- 25.0 DBA d 
386.4 --- 36.2 BALB/c d 
509.0 ± 28.6 AKR k 
NT C3H k 
NT C57BR k 
417.0 -+ 46.9 A/WY a 
NT A s 
421.0 --- 62.5 A/WY b 
464.3 ± 50.0 B a 
NT B s 
NT B k 
NT B d 
* Letters and numerals before a slash or period indicate the strain; numerals and letters after a slash indicate 
sublines and/or holders while numerals and letters after a period indicate the source of the introduced gene. 
t Mean - S.E. 
:~ Not tested. 
1 ml of the resulting chloroform phase was dried in 
a scintillation vial at 60 ° and counted with Instagel 
scintillation fluid. All  the samples were assayed in 
duplicate and averaged. 
MT II activity was assayed with 50 mM sodium 
borate buffer, pH 10, 1 mM [3H]SAM and 100 #g 
PMME by the procedure described above. The 
two products, phosphatidyldimethylethanolamine 
(PDME) and phosphatidylcholine (PC), were 
counted. 
To visualize reaction products, the chloroform 
phase was dried under nitrogen gas to prevent oxi- 
dation and the residue was dissolved in 50 #1 chloro- 
form-methanol  (2/1, v/v). The samples were applied 
to silica gel G chromatograph plates and developed 
in chloroform-methanol-H20 (75/24/4, by vol.). 
Commercially available markers of PE, PMME, 
PDME, and PC were cochromatographed with the 
samples, and the spots were visualized by spraying 
with 0.06% Rhodamine 6G solution. 
S-Adenosyl-L-[methyl-3H]methionine (5-15 Ci/ 
mmole) was purchased from ICN, Irvine, CA. [3H]- 
SAM (100-500mCi/mmole) was obtained from 
Amersham, Arlington Heights, IL. S-Adenosyl-L- 
homocysteine, PE, PMME, PDME, and PC were 
obtained from the Sigma Chemical Co., St. Louis, 
MO. All  other reagents were from Mallinckrodt, 
Paris, KY. 
RESULTS 
Methyltransferase I activity was determined as a 
function of the incorporation of 4/~M [3H]SAM into 
endogenous PE forming PMME. The radioactivity 
was quantified directly by counting the chloroform 
layer of the extraction, and the rate of reaction was 
found to be linear with time up to 40 min. PMME 
was visualized by thin-layer chromatography and, 
after scraping and counting of the spot, was found 
to contain approximately 75% of total radiolabel 
applied to the silica plate, i.e. 25% of the radio- 
activity in the chloroform extract was not recovered 
by the scraping procedure (or consisted of other 
compounds). 
Results of MT I assays on hepatocyte membranes 
from various inbred mouse strains are shown in Table 
1. Of the nine inbred strains studied, A/J showed the 
lowest MT I activity, while A K R  and C3H had 
the highest. The remainder (C57BL/6J, DBA/2J, 
A/WYSn, and A .SW)  were intermediate in their 
MT I activity. Lineweaver-Burk plots of various 
concentrations of [3H]SAM as an indirect measure- 
ment of substrate concentration provided pre- 
liminary data that the differences in MT I activity 
were due to differences in apparent Vmax. The K,n 
value appeared to be the same for all the strains 
(data not shown). 
We then measured MT I activity in hepatocyte 
membranes from H-2 congenic mouse strains. These 
results are also presented in Table 1. Four of the 
strains had varying haplotypes (H-2 a, H-2 d, H-2 ~, 
and H-2 k) on a C57BL genetic background, while 
one, A-BYSn, carried the H-2 b haplotype on the 
A/WY background. In all five strains, the level ~f 
enzyme activity corresponded to that of the donor H- 
2 haplotype. One inbred strain, A/WYSn, however, 
was found to have a higher level of MT I activity 
than the other H-2 a haplotypes. 
To localize the effects of H-2 on MT I activity 
observed in H-2 congenics to a particular region of 
the major histocompatibility complex, we assayed 
several recombinant haplotypes for this enzyme. The 
results are shown in Table 2. The increase in activity 
in the B10.A(3R), (4R), and (5R) hepatocyte mem- 
branes compared with those from the B10.A animals 
suggests that the K end of the H-2 complex is 
H-2 effects on transmembrane methylation 
Table 2. Methyltransferase I activity in recombinant H-2 haplotypes 
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MT I activity Haplotype of origin 
Strain N (fmoles//~g protein) Inbred partner Donor strain K A E S D 
A/J* 6 10.03 -+ 0.50t k k k d d 
C57BL/6,10Sn 8 19.63 --- 0.55 b b b b b 
B10.A 4 9.50 +-- 1 . 0 3  C57BLI0/Sn A/WY k k k d d 
B10.A(5R) 4 20.89 -+ 0 . 5 1  C57BL10/Sn A/WY b b k d d 
B10.A(4R) 3 25.78 --- 0 . 2 5  C57BL10/Sn A/WY k k b b b 
B10.A(3R) 3 18.64 + 0.78 C57BL10/Sn A/WY b b k d d 
B10.D2 3 15.84 -+ 0.18 C57BL10/Sn DBA/2J d d d d d 
B10.D2-H-2 dml 1 5.80 --- 0.11 C57BL10/Sn B10.D2 d d d d -  
A.TL 3 15.95 --- 0.52 A/SnSf A.SW s k k k d 
A.TH 3 15.34 - 0.27 A/SnSf B10.S s s s s d 
* MT I activity in the A/J strain appeared to be mediated by the effects of other non-H-2 genes of the A genetic 
background. This is suggested by the observation that, although A/J is a natural k/d recombinant haplotype, its MT 
I activity was nevertheless low, atypical of other K haplotypes. 
t Mean --- S.E. 
involved in the regulation of MT I activity. This is 
supported by the change in activity observed in the 
A.TL mice compared to the B10.BR strain. Cross- 
overs at the D end of the 1"1-2 complex do not appear 
to affect MT I activity, as illustrated by the A.TH 
recombinant haplotype and the B10.D2-H-2 dml 
mutant. 
Methyltransferase II activity was assayed by meas- 
uring the incorporation of tritium from [3H]SAM 
into exogenous PMME in the chloroform phase. The 
reaction products, PDME and PC, were visualized 
by thin-layer chromatography and found to have 
incorporated approximately 25 and 55% of total 
radiolabel, respectively, after 30 min of incubation. 
The reaction was determined to be linear with time 
up to 40 min. No significant differences were found 
among the inbred strains studied (Table 1). The 
Lineweaver-Burk plots for the A/J and C57BI./61 
strains did not show significant differences in the 
apparent Vmax or Km (data now shown). 
DISCUSSION 
Methylation of membrane phospholipids is 
mediated by two specific methyltransferases [7]. The 
first enzyme (MT I) methylates phosphatidyl- 
ethanolamine to phosphatidylmonomethylethanol- 
amine, requires magnesium, has a high affinity for 
S-adenosyl-L-methionine, and is believed to be 
located in the inner leaflet of the plasma membrane. 
The second enzyme (MT II) subsequently transfers 
two methyl groups to PMME to form phos- 
phatidylcholine, has a low affinity for S-adenosyl-L- 
methionine, does not require magnesium, and is 
believed to be located in the outer leaflet. The asym- 
metric distribution of these enzymes and their sub- 
strates within the membrane facilitates the trans- 
location of phospholipids across the matrix and 
results in changes in membrane fluidity [8]. These 
alterations in membrane fluidity have been pos- 
tulated to affect the coupling of ~adrenergic recep- 
tors to adenylate cyclase [3]. Phosphatidylcholine 
synthesis by transmembrane methylation appears to 
be under the control of several other hormones, 
including glucagon [9], angiotensin, and vasopressin 
[10], which modulate the activation of adenylate 
cyclase. Not all receptor-mediated processes, 
however, interact with this series of methylation 
reactions. Stimulation of platelets, for example, with 
thrombin, prostaglandin, or epinephrine, was with- 
out effect on transmethylation in these cells [3]. 
Phospholipid methylation was also found tobe  non- 
essential in amylase secretion and activation of 
adenylate cyclase by fl-adrenergic agonists in the 
guinea pig and rat parotid gland [11]. Since fl-adre- 
nergic stimulation of adenylate cyclase has been 
shown to depend on transmembrane methylation in 
other systems, species- and tissue-specific differences 
may be involved in the extent of interaction between 
phospholipid methylation and receptor-mediated 
response. 
Glucagon-stimulated adenylate cyclase activity has 
been found to be under the influence of the mouse 
major histocompatibility complex, H-2 [2]. Since the 
mode of action of glucagon in liver is analogous to 
that of the fl-adrenergic catecholamines, we inves- 
tigated the possible effects of the MHC on phospho- 
lipid methyltransferase activity in hepatocyte plasma 
membranes from inbred and H-2 congenic strains of 
mice. 
While phospholipid methyltransferase activity is 
also found in microsomal (27 .4 -  1.92pmoles/mg 
protein/30 min) and mitochondrial (9.82 --- 0.28 
pmoles/mg protein/30 min) fractions of rat and bov- 
ine brain, the highest specific activity is localized to 
the plasma membrane (28.0 - 0.73 pmoles/mg 
protein/30 rain) [12]. We utilized a 10-fold purified 
plasma membrane fraction of mouse liver to inves- 
tigate methyltransferase activity in inbred and H-2 
congenic strains. Variations in relative recoveries of 
components may contribute to, but do not fully 
explain, the variations in enzymatic activity that we 
found, since we found variations between strains that 
were as large as those between subcellular fractions, 
i.e. the plasma membrane fraction would have to 
consist entirely of one contaminant in one strain and 
entirely of another component in another strain. 
By measuring the incorporation of radioactivity 
from [3H]SAM into endogenous PE, we found sig- 
nificant variation among inbred strains of mice in 
3424 J. MARKOVAC and R. P. ERICKSON 
MT I activity (Table 1). Preliminary data suggest 
that this variation is due to differences in apparent 
Vmax while the Km values remained the same. Vari- 
ations in levels of endogenous substrate (PE) in the 
membranes are unlikely to contribute to the results 
since PE represents 20% of phospholipid, or 11% of 
total lipid, of mouse liver membranes [13], providing 
a large excess of endogenous substrate. Alterna- 
tively, strain variation in levels of methyltransferase 
inhibitors could contribute to the variations in enzy- 
matic activity found. 
MT I activity was subsequently measured in hepa- 
tocyte membranes from H-2 congenic strains. In five 
of the six strains tested, the level of methyltransferase 
activity corresponded to that of the donor H-2 haplo- 
type. The A/WYSn strain, however, showed a higher 
level of enzyme activity than did the other strains 
with the H-2 a haplotype. A possible explanation for 
this discrepancy might be attributed to the effects of 
genetic background on MT I. Studies with congenic 
lines focus on the effects of a single locus or small 
chromosomal segment (3-10 centiMorgans, in the 
case of H-2, [14]) on a particular phenotype, while 
the genetic background is kept constant. Under such 
circumstances, H-2 exerts significant effects on MT 
I activity. However, the A/J and A/WYSn strains, 
both originally of the A background, have been 
separated for over 100 generations. Even though 
both are H-2 a, the variation in the genetic back- 
grounds of these two strains could account for the 
difference in MT I activity. In their studies of the H- 
2 influence on liver cyclic AMP levels, Lafuse and 
co-workers [1] found a similar trend in strains of 
background A. These investigators concluded that 
the effect contributed by other (non-H-2) loci on this 
background overrode the effects of the MHC on 
glucagon responses. Interestingly, as seen in Table 
1, the basal MT I activities in the inbred and congenic 
strains all vary by increments of about five activity 
units. This may or may not be significant for the 
biochemical mechanisms of action of MT I. 
since Edidin and co-workers [1, 2] investigated 
the effects of H-2 on glucagon-stimulated cyclic AMP 
levels and an interaction exists between glucagon 
binding and membrane phospholipid N-methylation, 
we compared our results with theirs, finding a striking 
pattern. This is illustrated in Fig. 1. H-2 a, the haplo- 
type with the highest level of liver cyclic AMP and 
the lowest Km for glucagon, had the lowest MT I 
activity, while the haplotype with the highest MT I 
activity (H-2 k) had the lowest cyclic AMP levels and 
the highest Km for glucagon (r = 0.88). The others 
(H-2 b, H-2 d and H-2 s) were intermediate for all three 
variables. Furthermore, from their results of H-2 
recombinants, Lafuse et al. [1] concluded that at least 
two H-2 associated loci affect intracel!ular cyclic 
AMP levels, one of these mapping to the K end 
of the MHC. Our investigations using recombinant 
haplotypes indicated that this region is also involved 
in the control of MT I activity (Table 2). The excep- 
tion lies with the A/J strain which is a natural k/d 
recombinant haplotype. The K end is k, and yet 
A/J showed low basal MT I (unlike H-2k). This 
discrepancy may be attributed to the effects of other, 
non-H-2, genes previously observed in the A genetic 
background. The inbred partner of the series of 
crosses resulting in the A.TL and A.TH strains is 
A/SnSF. We were unable to obtain this strain. How- 
ever, A/Sn has been separated from A/WYSn for 
only 15-20 generations [15]. Since C57BL/10J and 
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Fig. 1. Plot of MT I activity versus intracellular cyclic AMP levels in inbred and H-2 congenic mice. 
Methyltransferase I activities are those shown in Table 1. Cyclic AMP values, expressed as pmoles 
cAMP/mg wet liver weight, are as given by Lafuse et al. [1]. 
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C57BI_/10Sn have been separated for over 30 gen- 
erations [15] with no change in Mt I activity between 
the two, we assume that A/Sn and A/WYSn have 
not diverged sufficiently to affect the activity of this 
enzyme. 
While Hirata et al. [8] and Castafio et al. [9] 
reported that phospholipid methylation increases fol- 
lowing fl-adrenergic and glucagon stimulation, 
respectively, the negative correlation of our results 
with those of Lafuse and coworkers does not con- 
tradict their findings. We determined basal levels of 
MT I activity without hormonal stimulation. Lower 
basal levels of membrane methyltransferase I might 
show a greater response to hormone-induced 
changes to achieve the same, or higher, end states. 
Preliminary results indicate that MT I activity is 
stimulated to the same levels by isoproterenol in 
the A/J and C57BL/6J strains [16]. Alternatively, 
continued in v ivo  stimulation could have led to 
greater "down regulation" in the more sensitive 
strain. 
Our investigations do not eliminate the possibility 
that H-2 may exert an effect on the endogenous levels 
of phosphatidylethanolamine in the cell membranes 
and, thus, contribute indirectly to the regulation of 
MT I, although it is unlikely given the high con- 
centration of PE in mouse liver plasma membranes. 
Furthermore,  the MHC may also be involved in 
the production of possible stimulatory or inhibitory 
modulators of MT I in certain strains. Although the 
biochemical role of the MHC in the regulation of MT 
I is not clear, striking correlations emerge between 
biological signals associated with H-2 or H L A  and 
those apparently mediated by phospholipid methyl- 
ation. Erickson et al. (manuscript in preparation) 
have found an H L A  association with the degree of 
lectin stimulation of lymphocytes. Increased 
phospholipid methyltransferase activity has been 
reported in analogous systems following stimulation 
with concanavalin A [17, 18]. Similarly, 1-1-2 antigens 
have been shown to influence killer T cell specificity 
and function [19], while the methylation of mem- 
brane phospholipids markedly increases during cyto- 
toxicity by these cells [20]. Correlations such as these, 
as well as that presented in this paper, suggest the 
possibility that differences in methyltransferase 
activity are involved in mediating those MHC 
associations. 
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